Researchers at Queen Mary University of London have identified a new therapy target, a protein called CEACAM7, that could be used to help treat pancreatic cancer.
The team managed to create a CAR T cell therapy using this target that was able to kill pancreatic cancer cells in the lab and also in a mouse model. Read more . . .